Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06556732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease

Name: Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease — clinical trial record (NCT06556732)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhasePhase 1

SponsorAssiut University

Started2024-08-10

View on ClinicalTrials.gov ↗

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

Assiut University

1,604 trials monitored

See 18 trials at risk

Atrial Fibrillation

1,126 trials monitored

See 49 trials at risk

This is a prospective comparative study, conducted at Cardiology Department, Aswan University Hospital on AF patients with structural heart disease. Eplerenone 25 mg daily will be given and searching for AF recurrence among study population.

Trial Details

NCT Number	NCT06556732
Lead Sponsor	Assiut University
Conditions	Atrial Fibrillation
Enrollment	100 participants
Start Date	2024-08-10
Primary Completion	2024-08-13 (estimated)
Study Completion	2024-08-31 (estimated)
Updated on ClinicalTrials.gov	2024-08-16